• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Mayne Pharma Group Ltd

+ Add to Watchlist

MYX:AU

0.7525 AUD 0.0025 0.33%

As of 23:23:55 ET on 09/14/2014.

Snapshot for Mayne Pharma Group Ltd (MYX)

Open: 0.7500 Day's Range: 0.7500 - 0.7550 Volume: 320,499
Previous Close: 0.7500 52wk Range: 0.5900 - 1.0450 1-Yr Rtn: +25.42%

Stock Chart for MYX

No chart data available.
  • MYX:AU 0.7525
  • 1D
  • 1M
  • 1Y
0.7500
Interactive MYX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MYX

Current P/E Ratio (ttm) 19.8939
Estimated P/E(06/2015) 19.2308
Relative P/E vs. AS51 1.0512
Earnings Per Share (AUD) (ttm) 0.0377
Est. EPS (AUD) (06/2015) 0.0390
Est. PEG Ratio 1.0284
Market Cap (M AUD) 440.73
Shares Outstanding (M) 587.63
30 Day Average Volume 1,678,557
Price/Book (mrq) 2.7717
Price/Sale (ttm) 2.9875
Dividend Indicated Gross Yield -%
Cash Dividend (AUD) 0.0078
Dividend Ex-Date 03/03/2011
5 Year Dividend Growth -
Next Earnings Announcement 02/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MYX

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for MYX

Mayne Pharma Group Ltd. develops and manufactures oral pharmaceuticals. The Company produces branded generics, specialty generics, and active pharmaceutical ingredients.

Scott RichardsCEO/Managing Dir/Executive DirMark CansdaleCFO/Secretary
Ilana StancovskiChief Scientific Officer
More Company Profile & Key Executives for MYX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil